Obesity Clinical Trial
— MODEOfficial title:
The MODE Trial: A Pilot Trial Investigating Planned Caesarean Section Versus Induction of Labour for Women With Class III Obesity
Canadian guidelines recommend that women with a pre-pregnancy body mass index (BMI) at or
above 40 kg/m2 deliver by their due date. When delivery is planned prior to spontaneous
labour, there are two options: planned induction of labour or pre-labour Caesarean
(C-section). However, it is not yet clear whether induction of labour or planned pre-labour
C-section is the best option for this population.
The MODE Trial aims to assess the feasibility of conducting a larger-scale trial of planned
mode of delivery in first time mothers who have a BMI >=40kg/m2, and obtain preliminary data
on health outcomes for moms and babies following delivery by either planned C-section or
induction of labour.
Status | Not yet recruiting |
Enrollment | 100 |
Est. completion date | August 31, 2021 |
Est. primary completion date | August 31, 2020 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Capability of participant to comprehend and comply with study requirements - Age =18 years at time of consent - Nulliparous (never given birth after 19+6/7 weeks of gestation) - Pre-pregnancy BMI or calculated BMI obtained in the first 13 weeks of pregnancy =40kg/ m2 - Participant plans to give birth in a participating site - Gestational age 34+0/7 - 36+6/7 weeks (based on estimated date of conception (EDC) assigned at the first ultrasound performed after 7+0/7 and prior to 20 +0/7 weeks) - Live fetus, documented positive heart rate at visit 1 prior to randomization - Singleton fetus in cephalic presentation at the time of randomization - No maternal or fetal contraindications to vaginal delivery Exclusion Criteria: - Known major fetal anomaly, confirmed by ultrasound or genetic testing - Multiple gestation - Known documented evidence of alcohol or drug abuse in this current pregnancy - Currently enrolled or has participated in another clinical trial within 3 months of the date of randomization (at discretion of Trial Coordinating Centre) |
Country | Name | City | State |
---|---|---|---|
Canada | The Ottawa Hospital | Ottawa | Ontario |
Lead Sponsor | Collaborator |
---|---|
Ottawa Hospital Research Institute | Canadian Institutes of Health Research (CIHR) |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Feasibility of conducting a larger-scale trial (eligibility criteria) | Appropriateness of eligibility criteria, measured by the reasons for exclusion of screened patients | 18 months | |
Primary | Feasibility of conducting a larger-scale trial (recruitment rate) | Eligibility and recruitment rate, measured by the proportion of patients who are eligible and recruited into the trial | 18 months | |
Primary | Feasibility of conducting a larger-scale trial (randomization) | Appropriateness of randomization, measured by the proportion of trial participants who consent to randomization | 18 months | |
Secondary | Maternal morbidity and mortality | Rates of: maternal death, admission to ICU, intrapartum Caesarean section, postpartum hemorrhage, postpartum wound infection, endometritis, venous thromboembolism (VTE), hypertensive disorders of pregnancy (gestational hypertension or preeclampsia), indication for Caesarean delivery, operative vaginal delivery, indication for operative vaginal delivery, uterine incision extensions during Caesarean section, chorioamnionitis, third or fourth degree perineal lacerations, induction agents, pain medication use during induction, labour, Caesarean section and postpartum. | Pregnancy to 6 week postpartum | |
Secondary | Fetal and neonatal morbidity and mortality | Rates of: stillbirth, neonatal death, gestational age at birth, birthweight, need for respiratory support within 72 hours of birth, duration of respiratory support, 5 minute Apgar <7, hypoxic-ischemic encephalopathy, seizure, infection (confirmed sepsis or pneumonia), meconium aspiration syndrome, birth trauma (bone fracture, neurologic injury or retinal hemorrhage), cephalohematoma, intracranial or subgaleal hemorrhage, or hypotension requiring vasopressor support, breastfeeding rates, hypoglycemia requiring intravenous treatment, jaundice requiring treatment, need for transfusion. | Pregnancy to 6 week postpartum | |
Secondary | Length of hospital stay | Length of hospital stay (in minutes) for both mom and baby | Start of induction to delivery; admission to delivery; and delivery until discharge, assessed up until 6-weeks postpartum | |
Secondary | Hospital readmission rates | The proportion of mothers and/or infants re-admitted to the hospital | Delivery to 6-weeks postpartum | |
Secondary | Techniques for induction of labour | What method was used for induction | Admission to hospital until delivery, assessed up to 7 days from hospital admission. | |
Secondary | Maternal satisfaction | Maternal satisfaction with study design and procedures, measured by a survey | Approximately 48-hours post-birth and 42+/-7 days postpartum | |
Secondary | Healthcare provider satisfaction | Healthcare provider satisfaction with study design and procedures, measured through a survey | 18 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |